Not Losing Weight on 0.5mg Wegovy — What's Actually Going On

The biggest myth about 0.5mg: that slow progress means Wegovy isn't working for you

People sometimes assume that if weight isn't moving by the second or third week at 0.5mg, the medicine has failed. That assumption misreads what this dose is for. Wegovy's schedule starts at 0.25mg for four weeks specifically to let your body adjust to semaglutide before the dose climbs. The 0.5mg step is the second rung of that same adjustment ladder, still building tolerance, not yet at the level where appetite suppression typically becomes pronounced enough to drive consistent weight loss.

The STEP 1 trial, published in the New England Journal of Medicine, recruited adults without diabetes and ran for 68 weeks. The roughly 15% average body-weight reduction reported in that trial was achieved at 2.4mg, a dose most participants didn't reach until around week 17. Expecting those results at week five or six on 0.5mg sets an unfair benchmark. The full Wegovy dosing schedule explains this step-by-step progression in detail.

If you're finding this phase frustrating, you're far from alone. A question our prescribers hear regularly is whether switching medicine or stopping early is worth considering. The short answer is: not yet. The evidence consistently shows that meaningful loss tends to follow dose escalation, not a change of medicine at this early stage.

What does affect how quickly 0.5mg Wegovy works, and what doesn't

A few things genuinely influence early progress. Energy intake matters: semaglutide reduces appetite, but it works alongside a reduced-calorie diet, not instead of one. If appetite suppression at 0.5mg is mild, food intake may not have shifted much yet. That's normal, and it's one reason the dose goes up.

Body weight and composition also play a role. Heavier starting weights tend to show larger absolute losses; lighter starting weights may show smaller kilos lost even if the percentage is similar. Week-to-week scales can be misleading too, fluid shifts, hormonal cycles and even a salty meal can mask half a kilogram of genuine fat loss.

What doesn't affect whether Wegovy works: the day of the week you inject, or whether you started mid-month rather than at the beginning. If the pharmacy ran out and you had to delay a dose by a few days over a holiday, that's a conversation for your prescriber rather than a reason to panic. The medicine's half-life means short gaps are rarely as damaging as people fear, but the right guidance is in your Patient Information Leaflet and from the clinician who prescribed it.

Lifestyle factors such as sleep quality, stress and physical activity do influence weight outcomes over time, the NHS healthy weight guidance covers the evidence on these clearly, and they're worth addressing alongside treatment rather than waiting for the dose to do all the work.

When slow progress at 0.5mg does warrant a closer look

There is a minority of people for whom dose escalation alone doesn't explain slow progress, and it's worth knowing the signs. If you've reached a higher dose (say, 1mg or beyond) and still aren't seeing movement after several months, that's a different question from the one this page addresses. At 0.5mg specifically, the bar for concern is high, because the dose hasn't yet reached its intended working level.

What does warrant a call to your prescriber: side effects severe enough that you've been unable to eat for days (which would accelerate loss temporarily but cause dehydration and other problems), or a concurrent health change such as a new medication that could be affecting your weight. Corticosteroids, some antidepressants and certain blood-pressure medicines are known to counteract weight-loss efforts. Your prescriber can review your full picture.

For context on where this dose sits in the wider journey, the page on which Wegovy dose tends to produce noticeable loss covers the evidence on when people typically report the shift. If you've already escalated to the maximum and progress has stalled, the guide on what to do when 2.4mg Wegovy isn't moving the scales is worth reading before drawing conclusions. And if you're researching options more broadly, the weight-loss treatment overview outlines what's currently licensed in the UK.

People considering cost as part of their decision can find honest context on the Wegovy price and cost page, worth reading before assuming a cheaper provider means the same clinical oversight.

What to do if you're genuinely concerned about your progress

Talk to your prescriber. That sounds obvious, but it bears saying plainly because the instinct is often to search for answers rather than raise them. Your prescriber can see your consultation history, your weight record and your dose timeline, context that no article can replicate.

At nume, every repeat order goes through a fresh clinical review by a GPhC-registered prescriber before anything is dispatched. That review exists partly for this reason: to catch situations where dose, timing or lifestyle support needs adjusting. It isn't a checkbox process. If you have concerns between orders, the aftercare team is available seven days a week.

If you're not yet on Wegovy and this page reached you during your research, the Wegovy overview covers licensing, eligibility and how the medicine works, and you can check your eligibility through a free consultation reviewed by one of our prescribers the same day it's submitted.